SYNGAP1 Syndrome and the Brain Gene Registry
Open Access
Abstract
Background: The human brain relies on complex synaptic communication regulated by key genes such as SYNGAP1. SYNGAP1 encodes the GTPase-Activating Protein (SYNGAP), a critical synaptic plasticity and neuronal excitability regulator. Impaired SYNGAP1 function leads to neurodevelopmental disorders (NDDs) characterized by intellectual disability (ID), epilepsy, and behavioral abnormalities. These variants disrupt Ras signaling, altering AMPA receptor transport and synaptic plasticity and contributing to cognitive and motor difficulties. Despite advancements, challenges remain in defining genotype–phenotype correlations and distinguishing SYNGAP1-related disorders from other NDDs, which could improve underdiagnosis and misdiagnosis. Brain Gene Registry: The Brain Gene Registry (BGR) was established as a collaborative initiative, consolidating genomic and phenotypic data across multiple research centers. This database allows for extensive analyses, facilitating improved diagnostic accuracy, earlier interventions, and targeted therapeutic strategies. The BGR enhances our understanding of rare genetic conditions and is critical for advancing research on SYNGAP1-related disorders. Conclusions: While no FDA-approved treatments exist for SYNGAP1-related disorders, several therapeutic approaches are being investigated. These include taurine supplementation, ketogenic diets, and molecular strategies such as antisense oligonucleotide therapy to restore SYNGAP1 expression. Behavioral and rehabilitative interventions remain key for managing developmental and cognitive symptoms. Advancing research through initiatives like the BGR is crucial for refining genotype–phenotype associations and developing precision medicine approaches. A comprehensive understanding of SYNGAP1-related disorders will improve clinical outcomes and patient care, underscoring the need for continued interdisciplinary collaboration in neurodevelopmental genetics.Keywords
Funding Information
- NIH (5U01 TR002764)
This publication has 27 references indexed in Scilit:
- Clinical variants paired with phenotype: A rich resource for brain gene curationGenetics in Medicine, 2023
- Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switchingNature Communications, 2023
- A call for an integrated approach to improve efficiency, equity and sustainability in rare disease research in the United StatesNature Genetics, 2022
- SYNGAP1 mutations: Clinical, genetic, and pathophysiological featuresInternational Journal of Developmental Neuroscience, 2019
- SYNGAP1 heterozygosity disrupts sensory processing by reducing touch-related activity within somatosensory cortex circuitsNature Neuroscience, 2018
- RAS Proteins and Their Regulators in Human DiseaseCell, 2017
- Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1Nature Genetics, 2013
- A Synaptic Ras-GTPase Activating Protein (p135 SynGAP) Inhibited by CaM Kinase IINeuron, 1998
- SynGAP: a Synaptic RasGAP that Associates with the PSD-95/SAP90 Protein FamilyNeuron, 1998
- The BrainScientific American, 1979